Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27913199)

  • 1. The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
    Dong R; Gong Y; Meng W; Yuan M; Zhu H; Ying M; He Q; Cao J; Yang B
    Cancer Lett; 2017 Mar; 388():43-53. PubMed ID: 27913199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium.
    Cao Y; Lin Y; Sun Y; Liu W; Shao Y; Zheng C
    Bioengineered; 2021 Dec; 12(1):151-161. PubMed ID: 33380244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6.
    Zhao H; Zhang X; Chen X; Li Y; Ke Z; Tang T; Chai H; Guo AM; Chen H; Yang J
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):311-321. PubMed ID: 25026504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
    Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
    Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
    Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
    Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
    PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages M2 polarization is involved in lapatinib-mediated chemopreventive effects in the lung cancer.
    Tariq M; Hussain N; Rehman K; Akash MSH; Al Haddad AHI; Said ASA; Fatease AA; Alamri A; Safhi AY; Sabei FY; Awadh AAA; Hussain M
    Biomed Pharmacother; 2023 May; 161():114527. PubMed ID: 36931028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
    Di Paolo D; Pastorino F; Zuccari G; Caffa I; Loi M; Marimpietri D; Brignole C; Perri P; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M; Pagnan G
    J Control Release; 2013 Sep; 170(3):445-51. PubMed ID: 23792118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages.
    Yao Z; Zhang J; Zhang B; Liang G; Chen X; Yao F; Xu X; Wu H; He Q; Ding L; Yang B
    Pharmacol Res; 2018 Jul; 133():121-131. PubMed ID: 29730267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles.
    Okuda T; Kawakami S; Higuchi Y; Satoh T; Oka Y; Yokoyama M; Yamashita F; Hashida M
    Int J Pharm; 2009 May; 373(1-2):100-6. PubMed ID: 19429294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration.
    Thaller C; Shalev M; Frolov A; Eichele G; Thompson TC; Williams RH; Dillioglugil O; Kadmon D
    J Clin Oncol; 2000 Nov; 18(22):3804-8. PubMed ID: 11078493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
    Maurer BJ; Kalous O; Yesair DW; Wu X; Janeba J; Maldonado V; Khankaldyyan V; Frgala T; Sun BC; McKee RT; Burgess SW; Shaw WA; Reynolds CP
    Clin Cancer Res; 2007 May; 13(10):3079-86. PubMed ID: 17505011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro.
    Ziv Y; Gupta MK; Milsom JW; Vladisavljevic A; Brand M; Fazio VW
    Anticancer Res; 1994; 14(5A):2005-9. PubMed ID: 7847841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide.
    Mo X; Zheng Z; He Y; Zhong H; Kang X; Shi M; Liu T; Jiao Z; Huang Y
    J Control Release; 2018 Oct; 287():12-23. PubMed ID: 30096402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
    Sogno I; Venè R; Sapienza C; Ferrari N; Tosetti F; Albini A
    Recent Results Cancer Res; 2009; 181():71-6. PubMed ID: 19213559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.